The inhibition or knockdown of sphingomyelinase in cancer or immune cells prevented IL6 production [37,38,39], whereas the promotion of cellular ceramide levels by increasing sphingomyelinase expression in bladder cancer cells enhanced IL6 production [39]. This evidence concerns the gene IL6 and urinary bladder carcinoma.